A comparison of neurodegeneration linked with neuroinflammation in different brain areas of rats after intracerebroventricular colchicine injection

Journal of Immunotoxicology

Volumn 13, Issue 2, 2016, Pages 181-190

  Sil, Susmita ^a   Ghosh, Rupsa ^a   Sanyal, Moumita ^a   Guha, Debjani ^a   Ghosh, Tusharkanti ^a  

^a UNIVERSITY OF CALCUTTA   (India)

Author keywords

Colchicine; hippocampus; neurodegeneration; neuroinflammation

Indexed keywords

BIOLOGICAL MARKER; COLCHICINE; INTERLEUKIN 1BETA; NITRITE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMATOLYSIS; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE SEVERITY; FRONTAL CORTEX; HIPPOCAMPUS; HISTOLOGY; LYSIS; MALE; MEMORY DISORDER; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NISSL SUBSTANCE; NONHUMAN; OCCIPITAL CORTEX; PARIETAL CORTEX; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; ANIMAL; BRAIN; CHEMICALLY INDUCED; COMPARATIVE STUDY; DEGENERATIVE DISEASE; DRUG EFFECTS; IMMUNOLOGY; MEMORY; PATHOLOGY; TIME FACTOR;

ANIMALS; BRAIN; COLCHICINE; MEMORY; NEURODEGENERATIVE DISEASES; RATS; TIME FACTORS;

EID: 84953319120     PISSN: 1547691X     EISSN: 15476901     Source Type: Journal    
DOI: 10.3109/1547691X.2015.1030804     Document Type: Article

References (53)

1. Alali, F., Tawaha, K., and Qasaymeh, R. M. 2004. Determination of colchicine in Colchicum steveni and C. hierosolymitanum (Colchicaceae): Comparison between two analytical methods. Phytochem. Anal. 15:27-29.
2. Albrecht, U., Yang, X., Asselta, R., et al. 2007. Activation of NF-αB by IL-1β blocks IL-6-induced sustained STAT3 activation and STAT3-dependent gene expression of the human gamma-fibrinogen gene. Cell Signal 19:1866-1878.
3. Aloisi, F. 2001. Immune function of microglia. Glia 36:165-179.
4. Angelucci, F., Spalletta, G., di Iulio, F., et al. 2010. Alzheimer's disease (AD) and mild cognitive impairment (MCI) patients are characterized by increased BDNF serum levels. Curr. Alzheimer Res. 7:15-20.
5. Austin, S. A., and Combs, C. K. 2008. Mechanisms of microglial activation by amyloid pre-cursor protein and its proteolytic fragments. In: Central Nervous System Diseases and Inflammation (Lane, T.E., Carson, M., Bergmann, C., and Wyss-Coray, T., Eds.). London: Springer, pp. 13-32.
6. Barone, E., Di Domenico, F., Cenini, G., et al. 2011. Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment. J. Alzheimers. Dis. 25:623-633.
7. Bell, K. F., and Claudio Cuello, A. 2006. Altered synaptic function in Alzheimer's disease. Eur. J. Pharmacol. 545:11-21.
8. Brickell, C. D. 1984. Colchicum L. In: Flora of Turkey and the East Aegean Islands (Davis, P.H., ed.). Edinburgh, UK: Edinburgh University Press, pp. 329-351.
9. Brilliant, M. J., Elble, R. J., Ghobrial, M., and Struble, R. G. 2003. The distribution of amyloid β protein deposition in corpus striatum of patients with Alzheimer's disease. Neuropathol. Appl. Neurobiol. 23: 322-325.
10. Brun, A., and Englund, E. 1981. Regional pattern of degeneration in Alzheimer's disease: Neuronal loss and histopathological grading. Histopathology 5:549-564.
11. Cox, G. 1977. Neuropathological techniques. In: Theory & Practice of Histological Techniques (Bancroft, J. D., and Stevens, A., Eds.), London: Elsevier, pp. 258-259.
12. Csolle, C., and Sperlagh, B. 2010. Peripheral origin of IL-1β production in rodent hippocampus under in vivo systemic bacterial lipoplysaccharide (LPS) challenge and regulation by P2X7 receptors. J. Neuroimmunol. 219:38-46.
13. Csölle, C., and Sperlagh, B. 2011. Endo-cannabinergic modulation of IL-1β in mouse hippo-campus under basal conditions and after in vivo systemic lipopolysaccharide stimulation. Neuroimmunomodulation 18: 226-231.
14. Cuénod, C. A., Denys, A., Michot, J. L., et al. 1993. Amygdala atrophy in Alzheimer's Disease: An in vivo magnetic resonance imaging study. Arch. Neurol. 50:941-945.
15. Drenth, J. P., and van der Meer, J. W. 2001. Hereditary periodic fever. New Engl. J. Med. 345:1748-1757.
16. Emerich, D. F., and Walsh, T. J. 1990. Cholinergic cell loss and cognitive impairments following intraventricular or intradentate injection of colchicine. Brain Res. 517:157-167.
17. Fan, Y., Dutta, J., Gupta, N., Fan, G., et al. 2008. Regulation of programmed cell death by NF-κB and its role in tumorigenesis and therapy. Adv. Exp. Med. Biol. 615:223-250.
18. Fanelli, F., Sepe, S., D'Amelio, M., et al. 2013. Age-dependent roles of peroxisomes in the hippocampus of a transgenic mouse model of Alzheimer's disease. Mol. Neurodeg. 8:8.
19. 2 induces programmed cell death in Trypanosoma brucei bloodstream form. Cell Death Diff. 12:335-346.
20. Ganguly, R., and Guha, D. 2008. Alzheimer's disease and protection by Moringa oleifera. Indian J. Med. Res. 128:744-751.
21. Gehrmann, J., Matsumoto, Y., and Kreutzberg, G. W. 1995. Microglia: Intrinsic immune effector cell of the brain. Brain Res. Rev. 20: 269-287.
22. Giuliani, D., Bitto, A., Galantucci, M., et al. 2014. Melanocortins protect against progression of Alzheimer's disease in triple-transgenic mice by targeting multiple pathophysiological pathways. Neurobiol. Aging 35: 537-547.
23. 15N]-nitrate in biological fluids. Anal. Biochem. 126:131-138.
24. Jacobs, H. I., van Boxtel, M. P., Jolles, J., et al. 2012. Parietal cortex matters in Alzheimer's disease: An overview of structural, functional and metabolic findings. Neurosci. Biobehav. Rev. 36: 297-309.
25. Ke, J., Long, X., Liu, Y., et al. 2007. Role of NF-κB in TNFα-induced COX-2 expression in synovial fibroblasts from human TMJ. J. Dent. Res. 86:363-367.
26. Koo, E. H., Sisodia, S. S., Archer, D. R., et al. 1990. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc. Natl. Acad. Sci. USA 87:1561-1565.
27. Kumar, A., Dogra, S., and Prakash, A. 2010. Protective effect of naringin, a citrus flavonoid, against colchicine-induced cognitive dysfunction and oxidative damage in rats. J. Med. Food 13:976-984.
28. Kumar, A., Naidu, P. S., Seghal, N., and Padi, S. S. 2007b. Neuroprotective effects of resveratrol against intra-cerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats. Pharmacology 79:17-26.
29. Kumar, A., Seghal, N., Naidu, P. S., et al. 2007a. Colchicine-induced neuro-toxicity as an animal model of sporadic dementia of Alzheimer's type. Pharmacol. Rep. 59:274-283.
30. Kumar, A., Sehgal. N., Puneet, K., et al. 2008. Protective effect of quercetin against icv colchicine-induced cognitive dysfunctions and oxidative damage in rats. Phytother. Res. 22:1563-1569.
31. Kumar, M. H., and Gupta, Y. K. 2002. Intra-cerebroventricular administration of colchicine produces cognitive impairment associated with oxidative stress in rats. Pharmacol. Biochem. Behav. 73:565-571.
32. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193: 265-275.
33. Mallat, M., and Chamak, B. 1994. Brain macrophages: Neurotoxic or neurotrophic effector cells? J. Leukocyte Biol. 56:416-422.
34. Minton, K. 2001. Immune mechanisms in neurological disorders: Protective or destructive? Trends Immunol. 22:655-657.
35. Mizuno, M., Yamada, K., Olariu, A., et al. 2000. Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a Radial Arm Maze test in rats. J. Neurosci. 20: 7116-7121.
36. Mouton, P. R., Martin, L., Calhoun, M., et al. 1998. Cognitive decline strongly correlates with cortical atrophy in Alzheimer's dementia. Neurobiol. Aging 19:371-377.
37. Nolan, Y., Vereker, E., Lynch, A. M., and Lynch, M. A. 2003. Evidence that lipopolysaccharide-induced cell death is mediated by accumulation of reactive oxygen species and activation of p38 in rat cortex and hippocampus. Exp. Neurol. 184:794-804.
38. Nyoman, G., and Darmadipura, S. 2007. Role of microglia as prime component of CNS immune system in acute and chronic neuroinflammation. Folica Med. Indonesiana 43:54-58.
39. Parikh, A. A., Moon, M., Pritts, T., et al. 2000. IL-1β induction of NF-κB activation in human intestinal epithelial cells is independent of oxyradical signaling. Shock 13:8-13.
40. Paxinos, G., and Watson, C., (Eds.). 1986. The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press.
41. Pitchaimani, V., Arumugam, S., Thandavarayan, R. A., et al. 2012. Nootropic activity of aceta-minophen against colchicine induced cognitive impairment in rats. Clin. Biochem. Nutr. 50:241-244.
42. Rai, S., Kamat, P. K., Nath, C., and Shukla, R. 2013. A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats. J. Neuroimmunol. 254:1-9.
43. Roy, C. 2014. Role of Moringa oleifera on hippocampal cell morphology and senile plaque formation in colchicine induced experimental rat model of Alzeimer's Disease. Intl. J. Curr. Pharm. Res. 6:51-54.
44. Sabuncu, M., Desikan, R., Sepulcre, J., et al. 2011. Dynamics of cortical and hippocampal atrophy in Alzheimer Disease. Arch. Neurol. 68: 1040-1048.
45. Shibli, R. A., Daradkah, N. Q., Makhadmeh, I. M., and Baghdadi, S. H. 2010. Colchicine production from colchicum and the role of in vitro cultures: A review. Jordan. J. Agric. Sci. 6:208-222.
46. Shigematsu, K., and McGeer, P. L. 1992. Accumulation of amyloid precursor protein in neurons after intraventricular injection of colchicine. Am. J. Pathol. 140:787-794.
47. Sil, S., Goswami, A. R., Dutta, G., and Ghosh, T. 2014. Effects of naproxen on some immune responses in colchicine induced rat model of Alzheimer's Disease. Neuroimmunomodulation 21: 304-321.
48. Socci, D. J., Bjugstad, K. B., Jones, H. C., et al. 1999. Evidence that oxidative stress is associated with the pathophysiology of inherited hydrocephalus in the H-Tx rat model. Exp. Neurol. 155: 109-117.
49. Stevens, A., and Bancroft, J. D., (Eds.). 1977. Proteins and nucleic acids. In: Theory and Practice of Histological Techniques. London: Elsevier, pp. 129.
50. Streit, W. J. 1993. Microglial-neuronal interactions. J. Chem. Neuroanat. 6:261-266.
51. Terkeltaub, R. A. 2003. Clinical practice. Gout. New. Engl. J. Med. 349: 1647-1655.
52. Trease, G. E., and Evans, W. C., (Eds.). 1989. Pharmacognosy. London: Elsevier, pp. 600-603.
53. Wilson, L. 1986. Microtubules as targets for drug and toxic chemical action: The mechanisms of colchicine and vinblastine. In: The Cytoskeleton - A Target for Toxic Agents (Clarkson, T. W., Sagar, P. R., and Syversen, T. L., Eds.). New York: Plenum Press, pp. 37-52.